Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease

NCT06932874 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

356

Enrollment

OTHER_GOV

Sponsor class

Conditions

Atherosclerotic Heart Disease
Type 2 Diabetes

Interventions

DRUG: Glucophage (Metformin Hydrochloride Tablets)
DRUG: New sustained-release metformin tablets (Ⅲ)

Sponsor

China National Center for Cardiovascular Diseases